세포생물학, 신약개발, 신경생물학, 약물전달

경력

• 2015.11~ present

CEO, Founder: ILIAS Biologics Incorporated

• 
  2012.03~ present

Professor, Department of Bio and Brain Engineering, KAIST

• 2009.10~ 2019.02

Chair, Optical Bioimaging Center, KAIST, Republic of Korea

• 2007.04 ~ 2019.02

Member, KI for the BioCentury, KAIST

• 2006.04 ~ present

Adjunctive professor, Graduate School of Medical Science and
Engineering, KAIST, Republic of Korea

• 2006.04 ~ 2013.02

Chair, BK21 Center for Bio-Medical Information Technology, KAIST, Republic of Korea

• 2005.03 ~ 2012.02

Associate Professor: Department of Bio and Brain Engineering, KAIST, Republic of Korea

• 2002.09~ 2005.02

Assistant Professor: Division of Molecular Life Sciences, Ewha Womans University, Republic of Korea

• 2001.10 ~ 2003.12

Research Instructor: Department of Cell Biology, UAB, USA

• 1999.04 ~ 2001.09

Postdoctoral Fellow: Department of Cell Biology, University of Alabama at Birmingham (UAB), USA

대표 연구실적

• 1. Exosome-based delivery of super-repressor IĸBa ameliorates kidney ischemia-reperfusion injury. Kidney International, 2021 May
• 2. The emerging role of exosomes as novel therapeutics: biology, technologies, clinical applications and the next. Am J Reprod Immunol, 2021 Feb
• 3. Exosomal delivery of NF-kB inhibitor delays LPS-induced preterm birth and modulates fetal immune cell profile in mouse models Sci Adv, 2021 Jan
• 4. Exosome-based delivery of super-repressor IkBa relieves sepsis-associated organ damage and mortality. Sci Adv, 2020 Apr
• 5. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nature Communications, 2016 July